Sirolimus (Rapamycin) Monotherapy Prevents Graft Vascular Disease in Nonhuman Primate Recipients of Orthotopic Aortic Allografts-Reference-Cited by-同舟云学术

Sirolimus (Rapamycin) Monotherapy Prevents Graft Vascular Disease in Nonhuman Primate Recipients of Orthotopic Aortic Allografts

Published:2003-05-13 Issue:18 Volume:107 Page:2369-2374
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Dambrin Camille¹,Klupp Jochen¹,Bîrsan Tudor¹,Luna Jorge¹,Suzuki Takeshi¹,Lam Tuan¹,Stähr Peter¹,Hausen Bernard¹,Christians Uwe¹,Fitzgerald Peter¹,Berry Gerald¹,Morris Randall¹

Affiliation:

1. From Transplantation Immunology, Cardiothoracic Surgery (C.D., J.K., T.B., T.L., B.H., R.M.), Cardiovascular Medicine (J.L., T.S., P.S., P.F.), and Pathology (G.B.), Stanford University, Stanford, and Biopharmaceutical Sciences, University of California, San Francisco (U.C.), San Francisco, Calif.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Coronary Artery Disease in the Transplanted Heart

2. Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides

3. Morris RE. New immunosuppressive drugs. In: Bussutil RW Klintmalm GB eds. Liver Transplantation. Philadelphia Pa: WB Saunders; 1996: 760–786.

4. Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

5. RAPAMYCIN INHIBITS ARTERIAL INTIMAL THICKENING CAUSED BY BOTH ALLOIMMUNE AND MECHANICAL INJURY

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gleevec and Rapamycin Synergistically Reduce Cell Viability and Inhibit Proliferation and Angiogenic Function of Mouse Bone Marrow-Derived Endothelial Progenitor Cells;Journal of Vascular Research;2021

2. Acute treatment of critical vascular stenoses with a bioabsorbable magnesium scaffold in infants with CHDs;Cardiology in the Young;2020-02-21

3. Validation of Donor-Specific Tolerance of Intestinal Transplant by a Secondary Heart Transplantation Model;Experimental and Clinical Transplantation;2017-02

4. Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab;Arquivos Brasileiros de Cardiologia;2015

5. Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial;American Journal of Transplantation;2014-07-10